Equine Healthcare Market size was valued at USD 1,265.7 million in 2021 and is poised to grow at a significant CAGR of 6.3% over 2022-2028. An increase in the incidence of various equine diseases such as Merial and West Nile virus coupled with the rise in R&D for the development and launch of newer therapeutics and vaccines is anticipated to boost the market over the forecast years. For instance, Boehringer Ingelheim focuses on the research and development of innovative medicines and therapies for equines. Such innovative equine products are Arti-Cell Forte and Aservo EquiHaler as a result, the company expands its market share in Australia. Moreover, in 2020, company spent USD 51.05 Mn on research and development platforms. It was more than 7% compared with 2019. The growth of the market is attributed to factors such as growing demand for equine animals, rising animal healthcare expenditure, surge in prevalence of equine diseases, rise in demand for horses for various purposes including horse racing, increase in adoption of equine nutritional supplements are significant drivers for the growth of the equine healthcare market over the forecast years.